Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Aurora Therapeutics is building a scalable platform for personalized gene editing to treat rare genetic diseases. They tailor CRISPR-based tools to individual mutations, addressing the hundreds or thousands of mutations that drive each disease. Their goal is to extend treatment to millions of patients by turning isolated gene-editing successes into a broad, scalable therapeutic platform.
Parse Score